Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alpine Immune Sciences Inc (ALPN)

Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,222,473
  • Shares Outstanding, K 65,546
  • Annual Sales, $ 58,880 K
  • Annual Income, $ -32,180 K
  • 60-Month Beta 1.14
  • Price/Sales 71.66
  • Price/Cash Flow N/A
  • Price/Book 11.40
Trade ALPN with:

Options Overview Details

View History
  • Implied Volatility 5.41% ( +0.40%)
  • Historical Volatility 119.09%
  • IV Percentile 1%
  • IV Rank 1.63%
  • IV High 178.10% on 10/20/23
  • IV Low 2.54% on 09/18/23
  • Put/Call Vol Ratio 1.35
  • Today's Volume 3,086
  • Volume Avg (30-Day) 2,871
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 42,041
  • Open Int (30-Day) 11,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.43
  • Number of Estimates 6
  • High Estimate -0.29
  • Low Estimate -0.51
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -53.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.25 +88.32%
on 04/08/24
64.57 -0.11%
on 04/12/24
+28.12 (+77.30%)
since 03/15/24
3-Month
18.56 +247.52%
on 01/24/24
64.57 -0.11%
on 04/12/24
+43.87 (+212.65%)
since 01/16/24
52-Week
6.71 +861.25%
on 05/04/23
64.57 -0.11%
on 04/12/24
+57.19 (+782.35%)
since 04/14/23

Most Recent Stories

More News
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock

Vertex just laid claim to an asset that might be very valuable.

VRTX : 394.17 (-0.80%)
ALPN : 64.50 (+0.12%)
Could This Stock Be the Next Biotech Buyout?

Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.

ALPN : 64.50 (+0.12%)
VRTX : 394.17 (-0.80%)
VERA : 42.57 (-8.51%)
Technology Stocks Power the Broader Market Higher

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stock indexes...

$SPX : 5,051.41 (-0.21%)
SPY : 503.53 (-0.18%)
$DOWI : 37,798.97 (+0.17%)
DIA : 377.98 (+0.18%)
$IUXX : 17,713.66 (+0.04%)
QQQ : 431.10 (+0.01%)
ZNM24 : 107-250 (+0.10%)
PARA : 10.43 (-4.31%)
AAPL : 169.38 (-1.92%)
TEAM : 194.85 (+1.57%)
NVDA : 874.15 (+1.64%)
AVGO : 1,329.06 (+1.40%)
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024

Stocks that traded heavily or had substantial price changes on Thursday: Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise

ALPN : 64.50 (+0.12%)
CONN : 3.85 (-3.02%)
NTIC : 14.89 (+0.13%)
BTUUQ : 1.1924 (+211.33%)
BTU : 24.09 (+5.01%)
NVS : 93.20 (-1.28%)
KMX : 69.80 (+0.49%)
FAST : 68.79 (-0.86%)
Stock Indexes Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) is up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. Stock indexes are higher even as bond...

$SPX : 5,051.41 (-0.21%)
SPY : 503.53 (-0.18%)
$DOWI : 37,798.97 (+0.17%)
DIA : 377.98 (+0.18%)
$IUXX : 17,713.66 (+0.04%)
QQQ : 431.10 (+0.01%)
ZNM24 : 107-250 (+0.10%)
GL : 59.97 (+7.45%)
KMX : 69.80 (+0.49%)
FAST : 68.79 (-0.86%)
GEN : 20.44 (-0.78%)
KVUE : 19.11 (-0.10%)
Stocks Slightly Higher as US Mar PPI Climbs Less Than Expected

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stock indexes this morning...

$SPX : 5,051.41 (-0.21%)
SPY : 503.53 (-0.18%)
$DOWI : 37,798.97 (+0.17%)
DIA : 377.98 (+0.18%)
$IUXX : 17,713.66 (+0.04%)
QQQ : 431.10 (+0.01%)
ZNM24 : 107-250 (+0.10%)
TEAM : 194.85 (+1.57%)
STZ : 257.78 (-0.29%)
AZN : 68.26 (-0.68%)
NVDA : 874.15 (+1.64%)
ALPN : 64.50 (+0.12%)
Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March

June S&P 500 E-Mini futures (ESM24) are up 0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up 0.17%% this morning, after the release of the PPI data.

ESM24 : 5,105.25 (+0.25%)
NQM24 : 17,898.00 (+0.09%)
DECK : 813.89 (-0.18%)
MCHP : 85.93 (+0.27%)
ADI : 191.23 (+0.49%)
MNDY : 187.92 (+1.99%)
NVDA : 874.15 (+1.64%)
JPM : 180.80 (-1.14%)
WFC : 56.41 (-0.98%)
C : 57.02 (-2.63%)
GLE.FP : 24.205 (-0.51%)
RLYB : 1.8000 (-1.64%)
Neurocrine Biosciences (NBIX) Reports Q1 Loss, Tops Revenue Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of -403.85% and 1.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 132.99 (+0.95%)
ALPN : 64.50 (+0.12%)
Alpine Immune Sciences Announces Participation in the Bank of America Securities Healthcare Conference

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the...

ALPN : 64.50 (+0.12%)
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Lags Revenue Estimates

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -51.85% and 73.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

ALPN : 64.50 (+0.12%)
BVS : 4.64 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based...

See More

Key Turning Points

3rd Resistance Point 64.63
2nd Resistance Point 64.57
1st Resistance Point 64.53
Last Price 64.50
1st Support Level 64.43
2nd Support Level 64.37
3rd Support Level 64.33

See More

52-Week High 64.57
Last Price 64.50
Fibonacci 61.8% 42.47
Fibonacci 50% 35.64
Fibonacci 38.2% 28.81
52-Week Low 6.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar